A major private hospital group has warned that a reimbursement cap under the Central Government Health Scheme is straining finances for hospitals treating advanced cancer. The cap on life-saving immunotherapy drugs is pushing essential medicines beyond affordability for many CGHS beneficiaries, according to the association, which says nine specific drugs are now out of reach and may limit access to treatment.
Insurers want a single empanelment system to make cashless treatment smoother for patients. Hospitals are skeptical, arguing the change could complicate billing, approvals, and operational workflows, effectively delaying care. ET Prime decodes the impact on hospitals, the insurance ecosystem, and the end customer—where the promised simplicity may not land evenly.
Your news, in seconds
Get the Beige app — every story in 60 words, updated hourly. Free on iOS & Android.
An insurers and hospitals meeting on October 9 has brought discharge delays back into focus, highlighting how policyholders continue to face waiting times during hospital discharge. The question now is whether coordination between insurers and healthcare providers can streamline approvals, documentation, and processes so patients spend less time caught between billing and discharge.
A new government notice aims to stop pharmaceutical companies from influencing doctors through vacations, gifts, and free educational materials. While the move targets unethical prescribing incentives, experts argue it’s unlikely to be effective without stronger enforcement and accountability mechanisms across the healthcare ecosystem.
Swipe through stories, personalise your feed, and save articles for later — all on the app.
